Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
Prions
|
protein particles that lack any type of genome
slowly progress noninflammatory neural degeneration =ataxia, dementia,death resistant to proteases |
|
viruses
|
smallest intracellular pathogen
no organized cellular structure have protein coat around nucleic acid of DNA or RNA unable to replicate outside of living cell |
|
bacteria
|
have both DNA and RNA
reproduce asexually no organelles single chromosomal |
|
fungi - 2 groups?
sample diseases? |
yeast or moulds
ringworm, athletes foot jock itch candida overgrowth |
|
parasites
|
unicellular with eukaryotic cell makeup(nucleus & organelles)
Ingest eggs or parasite to transmit scabies, chiggers, lice, fleas |
|
agents of infectious diseases
|
microorganisms that are usually not visible to human eye
|
|
epidemiology of infectious diseases
|
study of factors, events, circumstances that influence transmission of infectious diseases in human populations
|
|
what does epidemiology of infectious disease focus on?
|
incidence and prevalence
-# of new cases and #c of active cases source, portal of entry, site of infection,signs & symptoms |
|
portal of entry?
|
penetration
direct contact ingestion inhalation |
|
symtomology
|
collection of signs and symptoms (presentation of disease)
|
|
steps of Disease Course:
|
incubation
prodromal acute stage convalescents stage resolution stage |
|
Virulence factors:
|
substances or products that the infectious agent create that enhance ability of disease
|
|
toxins
|
alter or destroy the normal function of the host or host's cells
bacteria has 2 types; exotoxins/endotoxins |
|
adhesion factors:
evasive factors: |
adhesion; site specific or cell specific
evasive; blks/damages hosts immune response system ie; influenza has spikes that adhere to respiratory tract |
|
diagnoses;
|
need evidence, signs, symptoms,
lab work; culture, serology,antigens or metabolites made by pathogen |
|
serology
|
study of serum
|
|
treatment
|
aimed to eliminate the infectious organism, promote recovery
ways; antimicrobial, immunotherapy, surgical interventions |
|
3 types of abnormal immune responses
|
1-immunodeficiency
2-hypersensitivities 3-autoimmune disease |
|
immunodeficiency
2 types; primary/secondary |
primary: genetic/congenital
secondary: acquired |
|
examples of primary;
secondary: |
primary; thymus deficiency- Tcells don't mature
secondary; viral infection, marrow cancer, chemo drugs |
|
types of immune responses
|
1) cell mediated
2) humoral mediated 3)complement disorders 4)disorders of phagocytosis |
|
What cells type mediate immune response?
|
Lymphocytes; t cells & b cells
|
|
what are treatments for immune disorders?
|
replacement therapy, for issues producing antibodies
(gamma globulins) transplants, for problems making marrow or thymus |
|
Hypersensitivities
|
overexagerated or inappropriate immune response
causes inflammation and tissue damage |
|
what are 4 types of hypersensitivities?
ACID |
I- Allergy, IgE mediated hypersensitivity
II- Cytotoxic hypersensitivity III- Immune complex hypersensitivity 1,2,3=antibody mediated IV- Delayed or cell mediated hypersensitivity (T-cell mediated) |
|
samples of type 1 (allergy sensitivity)
|
allergic reactions
anaphalaxis asthma |
|
steps of 1st response to allergen
|
- allergen enters
- stimulates T-helper cells - helper T-s stimulate product of antibody (IgE) - antibodies bind to surface of mast cell - mast cells are sensitized |
|
What happens with 2nd exposure to allergen?
|
allergen will bind directly to mast cell
= inflammatory response or death |
|
what are the surface receptors on t-helpers and t-cytotoxics?
|
CD4/CD8
|
|
4 types of shock?
|
cardiogenic
hypovelemic obstructive distributive |
|
cardiogenic shock
|
cardiac arrest, inadequate flow
|
|
hypovelemic shock
|
internal bleeding, external blood loss
lower than normal volume |
|
obstructive shock
|
pulmonary embolism, physical obstructive of great vessels= NO blood flow
|
|
Distributive shock
|
form of relative hypovelemia d/t blood vessel dilation
= poor resistance |
|
anaphalactic shock
|
due to severe allergic reaction
type 1 hypersensitivity allergen binds antibody in mast cell severe vasodilation, edema, acute immune response bronchospasm circulatory failure |
|
septic shock
|
due to severe infection
vasodilators released inflammatory mediators released systemic response/no longer localized multi-organ dysfunction/incl; hypotension can quickly cause death |
|
describe type 2 hypersensitivity
|
IgM & IgG mediated, cytotoxic
surface receptors on normal body cells Ab binds Agin normal immune response causes normal cell destruction/complement is used to destroy cell plasma proteins trigger phahocytosis |
|
describe steps of type 3 hypersensitivity
|
(problem with the breakdown in the immune complex)
-immune complex passes through blood vessel -attaches to wall -when defences see, they destroy it, and normal tissue(blood vessel, joint) = tissue destruction =inflammation, damage, scar tissue forms -transcapillary exchange cant happen now |
|
describe type 4 hypersensitivity
|
NOT dependent on antibody(T-cell reaction)
-ag is presented to Tcell -Tcell is sensitized -cytotoxic T cell is formed to destroy antigen - inflammation - destruction of all cells w this antigen |
|
helper T cells
cytotoxic T cells |
essential for turning ON antibody production, activates cytotoxic
kill specific target cells, mediate direct lysis, kills all presenting cells (good or bad) |
|
2 types of immune response
|
immediate or delayed
|
|
what needs to happen in delayed immune response?
|
cytokines/lymphokines need to be produced
|
|
immunologic tolerance
|
able to recognize non-self from self
|
|
3 mechanisms of auto immune disorders
|
1)molecular mimicry
2)previously masked self antigens 3)abnormal T-cell activity |
|
molecular mimocry
|
microbe shares epitope with our body's cell
antibody is unable to tell diff between self / microbe |
|
Previously masked sef antigens
|
infections/autoimmune response may release and damage self-antigens/exposing epitomes of Af that has been hidden by immune
continued activation of new lymphocytes that recognize the previously hidden epitopes |
|
abnormal T-cell activity (super antigens)
|
triggers such as endotoxins =activation of large # Tcell
supressor cells are not produced therefore T-cells keep producing other components and attack self =inflammation & necrosis ie; systemic leupus erethmatosis |
|
neoplasia
|
process of altered cell growth & differentiation
• abnormal growth (mass) is formed and called a neoplasm • tumor (begnin or metastatic) • irreversible |
|
metaplasia
|
one normal cell type is replaced with anther normal cell type
|
|
dysplasia
|
a normal cell type replaced with abnormal cell type (pre-cancerous change)
|
|
anaplasia
|
loss of structural differentiation within a cell or group of cells often with increased capacity for multiplication - cancerous
|
|
malignanat
|
-cell undifferentiated, with anaplasia and atypical struction that does not resemble cells in original tissue
-the more undifferentiated, the more rapid the growth -grows by invasion, infiltrates surrounding tissue -can gain access to bvʼs and lymph channels to metastasize |
|
benign
|
well-differentiated cells that resemble original tissue
-progressive and slow, may stop growing or regress -grows by expansion, without invading surrounding tissues. Usually encapsulated -does not metastasize |
|
cancer causing genes
|
oncogenes
|
|
proto-oncogenes
|
-stimulate cellular division
-if mutated, uncontrolled cell division & growth may occur and cells may turn -cancerous -these genes encode for normal cell proteins such as growth factors |
|
tumour supressor genes
|
inhibit cell division
if damaged, cell division is uninhibited |
|
DNA repair genes
|
-checks to see if genetic code is correct & corrects it
-checks proto-oncogenes and tumor suppressor genes -mutations in the DNA repair genes often result in cancers cells being produced -this is usually the main target in cancer cells, leading to uncontrolled mutations -because the proto-oncogenes and tumor suppressor genes are directly affected. |
|
carcinoma
|
any malignant tumor derived from epithelial tissue; one of the four major
types of cancer |
|
sarcoma
|
a usually malignant tumor arising from connective tissue (bone or muscle etc.); one of the four major types of cancer
|
|
samples of tumours
|
adenoma; benign glandular epithelium
edenocarcinoma; malignant; glandular epithelium osteoma; benign tumour in bone |
|
how often does a tumour double in size?
|
every 100 days
|
|
methods of metastasis?
|
1invasion(whereitdevelops)andextension(tosurroundingtissue)
2. seedingviabodycavitiesdistancespread 3. (spreadvia)metastasisviabloodorlymph |
|
metastisis
|
1 ̊ to 2 ̊ site - spread of cancer cells
! ! most commonly metastasize to lymphatic tissue, then liver, lungs, bones ! ! then brain (largely supplied with bvʼs |
|
stage 1 of metastisis
|
-invades
-tumor grows, enters blood or lymph -emboli move in vessel -emboli, chunks of cell break off & grow on nearby tissues(these ones don't really survive) -one emboli enter the capillary bed and grow, but usually killed |
|
stage 2 of metastasis
|
distribution via blood or lymph
terminate travel and grow in area of resistance such as capillary bed or lymph node |
|
stage 3 of mestastasis
|
-angiogenesis: Possesses ability to form new blood vessels to bring nutrients to the secondary tumor
-established and thriving at 2 ̊ site |
|
pathogenesis of metastisis
|
1. Primary tumor
2. Metastatic subclone 3. Intravasation occurs (entersbloodvessel) 4. Interactswithlymphocytes 5. Tumorembolusformsandiscoatedwithplatelets 6.Extravasation occurs (tumor exits vessel to settle elsewhere) 7. Angiogensis occurs (tumor generates blood supply) |
|
cancer staging - 3 guiding characteristics
TNM |
1) Tumor – T: refers to the size and physical extent of the tumor
2) Node – N: refers to number of lymph nodes that have been invaded by the tumor 3) Metastasis – M: refers to the presence or abscence of metastases of the tumor cells |
|
tumour grading (TNM scale)
# refers to how many lymph nodes infected but extent of involvement |
when biopsy, graded on histology
I-IV |
|
TNMx
|
is tumour but cant be assessed
|
|
treatment
|
radiation; necrosis via free radicals
chemotherapy; cell division/ inhibits replication surgery; remove tumour/debulk and use chemo drugs after (combo-therapy) immunotherepy; vaccination, exposed to potent antigen (ie tb vaccine) hormone therapy combination therapy |
|
what are w major problems with the therapy
|
resumption of growth ; tumor regrows after 5 years
normal cells targeted- rapid proliferating cells, skin, GI tract etc are all affected |
|
transcapillary exchange
|
the primary function of the cardiovascular system. The exchange occurs between the capillary blood and the interstitial fluid surrounding tissue cells.! !
|
|
hydrostatic pressure
osmotic pressure |
hydrostatic; always out at arteriole end of capillary
osmotic; always in at venous end of capillary both are within capillary and interstitual space |
|
venous vs arteriole in hydrostatic pressure
|
Venous - hydrostatic pressure is lower, and therefore fluid moves into the vessel
Arterial – hydrostatic pressure is greater than the pressure within the capillary and fluid ! will move out |
|
residual fluid
|
excess fluid in interstitial space and is typically picked up by the lymph ! ! vessels, if not = edema
|
|
dehydration
|
volume deficit
|
|
causes of dehydration
|
inadequate intake
increases in GI metabolism Increase in renal output Increased diaphoresis – fluid lost through skin loss to third spacing -eg; tumour is a space occupying lesion – increases hydrostatic pressure |
|
3rd spacing (transcellular spacing)
|
Extracellular fluids are distributed between the interstitial compartment (i.e. tissue) and
intravascular compartment (i.e. plasma) in an approximately 75%-25% ratio. |
|
example of 3rd spacing
|
severe burns, pancreatitis ; fluid may lead out
|
|
edema
|
increase in interstitual fluid volume from vascular space
-can be life threatening (brain and lungs) |
|
causes of edema
|
increase capillary hydrostatic pressure > excess ISF
decrease colloid osmotic pressure > less pull into blood -obstructed lymph flow; will not be able to absorb residual fluid |
|
hypokelimia/hyperkelimia
|
hypokalemia; decrease in plasma potassium levals
hyperkalemia; increase in plasma potassium |
|
hypercalcemia
|
total plasma calcium concentration,
caused alot by malignancy |
|
Ph
|
ratio of the bicarbonate base to the volatile carbonic acid
normal Ph is 7.4 |
|
define acid and base
|
Acid is a molecule that can release an H+ ion
Base is a molecule that can accept or combine w/H+ |
|
what is the source of metabolic acids
|
fixed acid; not eliminated by the lungs but buffered by the body proteins or extracellular buffers such as HCO3(carbonic acid) and eliminated by the kidney.
|
|
3 forms of carbon dioxide transport and their contribution to acid base balance.
|
-plasma- H2CO3 formed from hydration of dissolved C02 that contributes to Ph
bicarbonate-carbon dioxde in excess of that which can be carried in plasma hemoglobin- |
|
respiratory acidosis
metabolic acidosis |
- decreased resp= increased carbon dioxide = decrease ph
-decreased blood ph, decreased production of hydrogen or the inabilty to form bicarbonate in the kindney which leads acidosis in the blood |
|
alakalosis of respiratory
metabolic alkalosis |
increased plasma pH and PCO2, increased H+ excretion and reabsorption
increased plasma pH and HCO3= decreased ventilation and increased PCo2 |